Dr.  

Gustavo Guillermo Garriga MArtina

, Spain


Presentations

Efficacy and safety of Ixekizumab in patients with moderate to severe psoriasis resistant to anti-TNF or anti-IL 09 October 2019 00:00 - 00:00

Abstracts

Efficacy and safety of Ixekizumab in patients with moderate to severe psoriasis resistant to anti-TNF or anti-IL Psoriasis More